Director Fernandes Prabhavathi buys 10,000 shares of OCGN at $0.91; stock at $0.94, -52.5% from 52-week high.
Director Fernandes Prabhavathi established an initial position of 10,000 shares at $0.91, representing a personal first investment in OCGN stock. The transaction occurred within a steep drawdown context: the stock trades at $0.94, down 52.5% from its 52-week high of $1.98, and has declined 22.3% over the prior 90 days. Ocugen is unprofitable on a full-year basis (net income $-13.0M most recently) but shows strong revenue growth of +142.6% year-over-year, suggesting meaningful business expansion despite ongoing losses. The modest transaction size and absence of prior holdings suggest this is a new director stake rather than a position accumulation by an existing shareholder.